Skip to main content
    P

    Pmv Pharmaceuticals Inc (PMVP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.19
    -0.08 (-6.30%)

    Market Cap: $95.93M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Pmv Pharmaceuticals Inc (PMVP) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Pmv Pharmaceuticals (PMVP) is expected to report earnings on Mar 4, 2027. In the quarter ended Sep 30, 2026, Pmv Pharmaceuticals reported EPS of -$0.29, below the -$0.28 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(14/25)
    Avg Surprise
    +6.10%

    Upcoming Estimates

    Reports Mar 4, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.26
    Range-$0.33 - -$0.19
    6 analysts
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.26
    Range-$0.30 - -$0.22
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.33+20.0%
    60d ago-$0.27+4.9%
    30d ago-$0.27+4.9%
    7d ago-$0.24-10.6%
    Current-$0.26
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    PMVP has an expected report date of Mar 4, 2027.

    Earnings History

    Of the 25 quarters below that had an estimate, PMVP beat 14, missed 10 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 94.44% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.29-$0.28-$0.41 - -$0.25-3.57%MissN/A21 up, 0 downNov 10, 2026
    Jun 30, 2026-$0.34-$0.38-$0.41 - -$0.38+10.53%BeatN/A31 up, 0 downAug 13, 2026
    Mar 31, 2026-$0.34-$0.38-$0.41 - -$0.37+10.53%BeatN/A41 up, 0 downMay 12, 2026
    Dec 31, 2025-$0.34-$0.42N/A+18.07%BeatN/A41 up, 0 downMar 6, 2026
    Sep 30, 2025-$0.40-$0.40-$0.43 - -$0.390.00%In lineN/A42 up, 0 downNov 12, 2025
    Jun 30, 2025-$0.41-$0.39-$0.40 - -$0.37-5.13%MissN/A42 up, 0 downAug 7, 2025
    Mar 31, 2025-$0.34-$0.38-$0.41 - -$0.37+10.53%BeatN/A31 up, 0 downMay 9, 2025
    Dec 31, 2024-$0.45-$0.38-$0.41 - -$0.33-18.42%MissN/A32 up, 0 downMar 3, 2025
    Sep 30, 2024-$0.37-$0.36-$0.39 - -$0.32-2.78%MissN/A70 up, 0 downNov 7, 2024
    Jun 30, 2024-$0.02-$0.36-$0.41 - -$0.31+94.44%BeatN/A60 up, 0 downAug 8, 2024
    Mar 31, 2024-$0.30-$0.37-$0.46 - -$0.29+18.92%BeatN/A60 up, 0 downMay 9, 2024
    Dec 31, 2023-$0.31-$0.39-$0.43 - -$0.32+20.51%BeatN/A51 up, 0 downFeb 29, 2024
    Sep 30, 2023-$0.34-$0.45-$0.46 - -$0.43+24.44%BeatN/A61 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.38-$0.47-$0.50 - -$0.43+19.15%BeatN/A60 up, 0 downAug 9, 2023
    Mar 31, 2023-$0.42-$0.46-$0.49 - -$0.39+8.70%BeatN/A60 up, 0 downMay 10, 2023
    Dec 31, 2022-$0.43-$0.44-$0.45 - -$0.41+2.27%BeatN/A60 up, 0 downMar 1, 2023
    Sep 30, 2022-$0.40-$0.41-$0.44 - -$0.41+2.44%BeatN/A60 up, 0 downNov 8, 2022
    Jun 30, 2022-$0.38-$0.41N/A+7.32%BeatN/AN/A0 up, 0 downAug 9, 2022
    Mar 31, 2022-$0.41-$0.39-$0.45 - -$0.31-5.13%MissN/A60 up, 0 downMay 10, 2022
    Dec 31, 2021-$0.40-$0.35-$0.37 - -$0.30-14.29%MissN/A6N/AMar 1, 2022
    Sep 30, 2021-$0.33-$0.30-$0.33 - -$0.25-10.00%MissN/A6N/ANov 12, 2021
    Jun 30, 2021-$0.29-$0.28-$0.30 - -$0.25-3.57%MissN/A5N/AAug 13, 2021
    Mar 31, 2021-$0.26-$0.24-$0.28 - -$0.21-8.33%MissN/A3N/AMay 14, 2021
    Dec 31, 2020-$0.63-$0.67N/A+5.97%BeatN/AN/AN/AMar 3, 2021
    Sep 30, 2020-$0.65-$0.50-$0.50 - -$0.19-30.00%MissN/A2N/ANov 13, 2020
    Jun 30, 2020-$0.48N/AN/AN/AN/AN/AN/AN/ASep 25, 2020
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.49, after -$1.14 the year before. It was -$1.76 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.49N/A
    Dec 31, 2024-$1.14N/A
    Dec 31, 2023-$1.45N/A
    Dec 31, 2022-$1.62N/A
    Dec 31, 2021-$1.28N/A
    Dec 31, 2020-$1.76N/A

    Frequently Asked Questions About PMVP

    When is Pmv Pharmaceuticals's next earnings date?

    Pmv Pharmaceuticals's next earnings report is expected for Mar 4, 2027.

    Did PMVP beat earnings estimates last quarter?

    No. Pmv Pharmaceuticals reported EPS of -$0.29 for the quarter ended Sep 30, 2026, below the -$0.28 estimate by 3.57%.

    What EPS do analysts expect from PMVP next quarter?

    The consensus EPS estimate for Pmv Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.26 from 6 analysts, with estimates from -$0.33 to -$0.19.

    How often does PMVP beat earnings estimates?

    Pmv Pharmaceuticals beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +2.82%.